Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Correction for ‘Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35’ by Mengying Wei et al., RSC Adv., 2019, 9, 18308–18319. DOI: 10.1039/C9RA00302A.

Detalles Bibliográficos
Autores principales: Wei, Mengying, Liu, Yuanyuan, Pi, Zifeng, Yue, Kexin, Li, Shizhe, Hu, Mingxin, Liu, Zhiqiang, Song, Fengrui, Liu, Zhongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695072/
https://www.ncbi.nlm.nih.gov/pubmed/35426990
http://dx.doi.org/10.1039/d1ra90081a
_version_ 1784619500729008128
author Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
author_facet Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
author_sort Wei, Mengying
collection PubMed
description Correction for ‘Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35’ by Mengying Wei et al., RSC Adv., 2019, 9, 18308–18319. DOI: 10.1039/C9RA00302A.
format Online
Article
Text
id pubmed-8695072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-86950722022-04-13 Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35 Wei, Mengying Liu, Yuanyuan Pi, Zifeng Yue, Kexin Li, Shizhe Hu, Mingxin Liu, Zhiqiang Song, Fengrui Liu, Zhongying RSC Adv Chemistry Correction for ‘Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35’ by Mengying Wei et al., RSC Adv., 2019, 9, 18308–18319. DOI: 10.1039/C9RA00302A. The Royal Society of Chemistry 2021-02-15 /pmc/articles/PMC8695072/ /pubmed/35426990 http://dx.doi.org/10.1039/d1ra90081a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title_full Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title_fullStr Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title_full_unstemmed Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title_short Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
title_sort correction: investigation of plasma metabolomics and neurotransmitter dysfunction in the process of alzheimer’s disease rat induced by amyloid beta 25-35
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695072/
https://www.ncbi.nlm.nih.gov/pubmed/35426990
http://dx.doi.org/10.1039/d1ra90081a
work_keys_str_mv AT weimengying correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuyuanyuan correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT pizifeng correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT yuekexin correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT lishizhe correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT humingxin correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuzhiqiang correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT songfengrui correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuzhongying correctioninvestigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535

Ejemplares similares